Previously Treated Childhood Rhabdomyosarcoma Completed Phase 2 Trials for Sorafenib (DB00398)

IndicationStatusPhase
DBCOND0028747 (Previously Treated Childhood Rhabdomyosarcoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01502410Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid CancerTreatment